Advertisement
Australia markets closed
  • ALL ORDS

    8,022.90
    -54.00 (-0.67%)
     
  • AUD/USD

    0.6688
    +0.0038 (+0.57%)
     
  • ASX 200

    7,783.00
    -55.80 (-0.71%)
     
  • OIL

    81.35
    +0.52 (+0.64%)
     
  • GOLD

    2,321.90
    -8.90 (-0.38%)
     
  • Bitcoin AUD

    92,167.72
    +841.42 (+0.92%)
     
  • CMC Crypto 200

    1,277.94
    -5.85 (-0.46%)
     

Oxurion Announces Extraordinary General Shareholders’ Meeting

Oxurion NV
Oxurion NV

Oxurion Announces Extraordinary General Shareholders’ Meeting

Leuven, BELGIUM – June 4, 2024 – 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces an extraordinary general shareholders’ meeting to be held on Thursday July 4, 2024 at 11:00 AM (CET).

This extraordinary general shareholders’ meeting regards the proposal of share consolidation in respect of all outstanding shares of the Company by means of a 1-for-10,000 share consolidation.

The convening notice and other documents pertaining to the shareholders’ meeting, can be consulted on Oxurion’s website Oxurion/shareholders.

ADVERTISEMENT

About Oxurion

Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at www.oxurion.com.

Please contact for additional information:

Oxurion NV
Pascal Ghoson
Chief Executive Officer
pascal.ghoson@oxurion.com

Backstage Communication
Jurgen Vluijmans
Partner
jurgen@backstagecom.be

Attachment